Citation 1: Konecki DS, Benedum UM, Gerdes HH, et al. The primary structure of human chromogranin A and pancreastatin. J Biol Chem. 1987;262(35):17026-30. Published 1987 Dec 15. doi:
Citation 2: Helman LJ, Ahn TG, Levine MA, et al. Molecular cloning and primary structure of human chromogranin A (secretory protein I) cDNA. J Biol Chem. 1988;263(23):11559-63. Published 1988 Aug 15. doi:
Citation 3: Mouland AJ, Bevan S, White JH, et al. Human chromogranin A gene. Molecular cloning, structural analysis, and neuroendocrine cell-specific expression. J Biol Chem. 1994;269(9):6918-26. Published 1994 Mar 4. doi:
Citation 4: Ota T, Suzuki Y, Nishikawa T, et al. Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004;36(1):40-5. Published 2004 Jan. doi:10.1038/ng1285
Citation 5: Heilig R, Eckenberg R, Petit JL, et al. The DNA sequence and analysis of human chromosome 14. Nature. 2003;421(6923):601-7. Published 2003 Feb 6. doi:10.1038/nature01348
Citation 6: Gerhard DS, Wagner L, Feingold EA, et al. The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004;14(10B):2121-7. Published 2004 Oct. doi:10.1101/gr.2596504
Citation 7: Wilson BS, Phan SH, Lloyd RV, et al. Chromogranin from normal human adrenal glands: purification by monoclonal antibody affinity chromatography and partial N-terminal amino acid sequence. Regul Pept. 1986;13(3-4):207-23. Published 1986 Feb. doi:10.1016/0167-0115(86)90040-6
Citation 8: Tamamura H, Ohta M, Yoshizawa K, et al. Isolation and characterization of a tumor-derived human protein related to chromogranin A and its in vitro conversion to human pancreastatin-48. Eur J Biochem. 1990;191(1):33-9. Published 1990 Jul 20. doi:10.1111/j.1432-1033.1990.tb19090.x
Citation 9: Sekiya K, Ghatei MA, Minamino N, et al. Isolation of human pancreastatin fragment containing the active sequence from a glucagonoma. FEBS Lett. 1988;228(1):153-6. Published 1988 Feb 8. doi:10.1016/0014-5793(88)80606-9
Citation 10: Curry WJ, Shaw C, Johnston CF, et al. Isolation and primary structure of a novel chromogranin A-derived peptide, WE-14, from a human midgut carcinoid tumour. FEBS Lett. 1992;301(3):319-21. Published 1992 Apr 27. doi:10.1016/0014-5793(92)80266-j
Citation 11: Orr DF, Chen T, Johnsen AH, et al. The spectrum of endogenous human chromogranin A-derived peptides identified using a modified proteomic strategy. Proteomics. 2002;2(11):1586-600. Published 2002 Nov. doi:10.1002/1615-9861(200211)2:11<1586::AID-PROT1586>3.0.CO;2-K
Citation 12: Kirchmair R, Benzer A, Troger J, et al. Molecular characterization of immunoreactivities of peptides derived from chromogranin A (GE-25) and from secretogranin II (secretoneurin) in human and bovine cerebrospinal fluid. Neuroscience. 1994;63(4):1179-87. Published 1994 Dec. doi:10.1016/0306-4522(94)90582-7
Citation 13: Gadroy P, Stridsberg M, Capon C, et al. Phosphorylation and O-glycosylation sites of human chromogranin A (CGA79-439) from urine of patients with carcinoid tumors. J Biol Chem. 1998;273(51):34087-97. Published 1998 Dec 18. doi:10.1074/jbc.273.51.34087
Citation 14: Taylor CV, Taupenot L, Mahata SK, et al. Formation of the catecholamine release-inhibitory peptide catestatin from chromogranin A. Determination of proteolytic cleavage sites in hormone storage granules. J Biol Chem. 2000;275(30):22905-15. Published 2000 Jul 28. doi:10.1074/jbc.M001232200
Citation 15: Giorgianni F, Beranova-Giorgianni S, Desiderio DM, et al. Identification and characterization of phosphorylated proteins in the human pituitary. Proteomics. 2004;4(3):587-98. Published 2004 Mar. doi:10.1002/pmic.200300584
Citation 16: Briolat J, Wu SD, Mahata SK, et al. New antimicrobial activity for the catecholamine release-inhibitory peptide from chromogranin A. Cell Mol Life Sci. 2005;62(3):377-85. Published 2005 Feb. doi:10.1007/s00018-004-4461-9
Citation 17: Beranova-Giorgianni S, Zhao Y, Desiderio DM, et al. Phosphoproteomic analysis of the human pituitary. Pituitary. 2006;9(2):109-20. Published 2006. doi:10.1007/s11102-006-8916-x
Citation 18: Mahapatra NR, Mahapatra NR. Catestatin is a novel endogenous peptide that regulates cardiac function and blood pressure. Cardiovasc Res. 2008;80(3):330-8. Published 2008 Dec 1. doi:10.1093/cvr/cvn155
Citation 19: Nilsson J, Rüetschi U, Halim A, et al. Enrichment of glycopeptides for glycan structure and attachment site identification. Nat Methods. 2009;6(11):809-11. Published 2009 Nov. doi:10.1038/nmeth.1392
Citation 20: Mahata SK, Mahata M, Fung MM, et al. Catestatin: a multifunctional peptide from chromogranin A. Regul Pept. 2010;162(1-3):33-43. Published 2010 Jun 8. doi:10.1016/j.regpep.2010.01.006
Citation 21: Aung G, Niyonsaba F, Ushio H, et al. Catestatin, a neuroendocrine antimicrobial peptide, induces human mast cell migration, degranulation and production of cytokines and chemokines. Immunology. 2011;132(4):527-39. Published 2011 Apr. doi:10.1111/j.1365-2567.2010.03395.x
Citation 22: Halim A, Rüetschi U, Larson G, et al. LC-MS/MS characterization of O-glycosylation sites and glycan structures of human cerebrospinal fluid glycoproteins. J Proteome Res. 2013;12(2):573-84. Published 2013 Feb 1. doi:10.1021/pr300963h
Citation 23: Mohseni S, Emtenani S, Emtenani S, et al. Antioxidant properties of a human neuropeptide and its protective effect on free radical-induced DNA damage. J Pept Sci. 2014;20(6):429-37. Published 2014 Jun. doi:10.1002/psc.2634
Citation 24: Bian Y, Song C, Cheng K, et al. An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014;96:253-62. Published 2014 Jan 16. doi:10.1016/j.jprot.2013.11.014
Citation 25: Preece NE, Nguyen M, Mahata M, et al. Conformational preferences and activities of peptides from the catecholamine release-inhibitory (catestatin) region of chromogranin A. Regul Pept. 2004;118(1-2):75-87. Published 2004 Apr 15. doi:10.1016/j.regpep.2003.10.035
Citation 26: Wen G, Mahata SK, Cadman P, et al. Both rare and common polymorphisms contribute functional variation at CHGA, a regulator of catecholamine physiology. Am J Hum Genet. 2004;74(2):197-207. Published 2004 Feb. doi:10.1086/381399
Citation 27: Mahata SK, Mahata M, Wen G, et al. The catecholamine release-inhibitory 'catestatin' fragment of chromogranin a: naturally occurring human variants with different potencies for multiple chromaffin cell nicotinic cholinergic responses. Mol Pharmacol. 2004;66(5):1180-91. Published 2004 Nov. doi:10.1124/mol.104.002139
Citation 28: Rao F, Wen G, Gayen JR, et al. Catecholamine release-inhibitory peptide catestatin (chromogranin A(352-372)): naturally occurring amino acid variant Gly364Ser causes profound changes in human autonomic activity and alters risk for hypertension. Circulation. 2007;115(17):2271-81. Published 2007 May 1. doi:10.1161/CIRCULATIONAHA.106.628859
Citation 29: Biswas N, Vaingankar SM, Mahata M, et al. Proteolytic cleavage of human chromogranin a containing naturally occurring catestatin variants: differential processing at catestatin region by plasmin. Endocrinology. 2008;149(2):749-57. Published 2008 Feb. doi:10.1210/en.2007-0838